ARCHIVES

November issue of Business & Regulatory Report, an additional 8 pages, included in this issue.

This article is from The Cancer Letter archive.

Vol. 30 No. 44 | November 19, 2004

Download PDF Visit The Full Archive

Related Articles

Seffrin; First Year ACS Shows “Simple Problems Aren’t”

August 6, 1993

UK’s NICE Set to Deny Payments For Zaltrap In Second-Line Metastatic Colorectal Cancer

June 26, 2013

Shubik Warns NCA Members They May Be Prober’s Next Target

May 22, 1981

NCI, NSF fund awards in nanotech training.

September 23, 2005

NCI Programs: BSA Approves $30M 5-Year Set-Aside For Leadership Initiative On Cancer

November 20, 1998

NCI Expects Centers To Increase Cancer Control Efforts Despite Various Obstacles They Face

January 16, 1987